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ABSTRACT
Objective: Cancer is a leading cause of death worldwide.
Likewise, in Pakistan, it is a major health problem, with
an approximate increase each year. Cancer treatment,
particularly chemotherapy, produces a detrimental effect
on individuals’ well‑being. Since the past few years, quality
of life (QOL) is considered as the primary goal of cancer
treatment in patients’ survival. This study aimed to assess
the QOL and its determinants in adult cancer patients
undergoing chemotherapy treatment. Methods: An analytical
cross‑sectional design was employed to achieve the study
objectives, utilizing consecutive sampling technique. A total
of 150 adult (>19 years) cancer patients were recruited
from a Tertiary Care Hospital in Karachi, Pakistan. The data
were collected using the Functional Assessment of Cancer
Therapy‑General, a QOL questionnaire. Multiple linear
regression was run to determine the effect of predictor
variables, with a mean QOL score. Results: The overall mean
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score of QOL as 57.37. The domains of physical and emotional
well‑being were mainly affected by the chemotherapy
treatment. Variables such as no previous hospitalization and
no significant changes in life events were positively associated
with the QOL. On the other hand, being female, unemployed,
chemotherapy side effects (>1 week), impaired socialization,
and discrimination by family/relatives were negatively
associated with the QOL. Conclusions: The study findings
suggested an overall low QOL among adult cancer patients
undergoing chemotherapy treatment. It is recognized as a
stressful treatment, which adversely affects the QOL of cancer
patients. Interventions should focus on both the physical and
psychological issues and need to be addressed to improve the
QOL of adult cancer patients.
Key words: Cancer, chemotherapy, emotional well‑being,
physical well‑being, quality of life, social well‑being
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Introduction
Cancer is the second most common cause of deaths
worldwide.[1] About 8.2 million people died due to different
cancers in 2012.[2] In Asia, the incident rate of cancer is
expected to increase from 6.1 to 10.7 million in 2030, with an
estimated increase in mortality rate from 4.1 to 7.5 million
in 2030.[3] Likewise, the rate of cancer is escalating in
Pakistan; in 2012, of its 173 million people, 1.4 million
were reported as cases of cancer, with an expected rise in
the incident rate of 150,000 cases each year.[4]
Cancer affects a person’s quality of life (QOL) in all
domains. The impairment in the QOL starts from the
diagnosis of cancer and continues with the aggressive nature
of treatment. Chemotherapy is one of the most common
treatment modalities that patients receive to combat cancer.
Among 65% of the cancer population, 25% patients receive
chemotherapy as the first line of treatment.[5] Chemotherapy
is used to treat cancers by killing the rapidly growing abnormal
cells and is believed to lower the recurrence of cancer and
increase the survival rate of patients.[6] However, besides these
therapeutic effects, it also has serious adverse effects which
can have detrimental effects on the QOL of an individual.
Moreover, chemotherapy treatment is administered for a long
time duration to get the desired effect and requires frequent
hospitalization for disease management, which poses an
additional burden on cancer patients.[7]
Unlike other therapies, chemotherapy exhibits several
systemic side effects that are difficult to tolerate. The
most commonly reported side effects experienced by
patients during and after chemotherapy cycles include
nausea/vomiting, thrombocytopenia, mouth ulcers, and
fatigue.[8‑11] These adverse effects affect a person’s ability to
work and decrease their functional capacity. The symptoms
are not limited to physical dysfunction only, but they
also interfere with patients’ psychological and emotional
stability. An investigation conducted on female cancer
patients showed that all the women who were working
at the beginning of the chemotherapy treatment left their
employments gradually with increase in the cycles due to
the discouraging attitude of the employers.[12] Consequently,
the individuals felt isolated, financially dependent on
their families, and eventually, they lost interest in their
life. Altered body image, that is, alopecia, an extremely
distressing symptom, prevents people from going out for
socialization and limits their normal life enjoyments.[13]
In addition, the financial implication associated with the
treatment is an added burden, which eventually affects the
overall functioning of an individual.[14] Thus, chemotherapy
treatment produces an enormous physical, psychological,
and emotional trauma among cancer patients, influencing
their overall QOL.

The effects of chemotherapy may vary among individuals
based on several factors, such as age, gender, cancer site,
and stage of the disease. The findings of an American study
indicated that older adults (65 and older) demonstrated
better coping and QOL scores in comparison with young
adult cancer patients.[15]
In a cross‑sectional study, it was found that being a female
was significantly (P = 0.009) associated with psychological
stress as compared to male gender.[16] Different cancer sites
also adversely affect the QOL. A research study reported
significant higher distress levels (P ≤ 0.001) in breast and
digestive tract cancer patients as compared to those suffering
from other cancer sites.[17] In addition to this, disease stage
is also found to be a predictor of QOL. A cross‑sectional
investigation was carried out among cervical cancer patients
revealed a significant decline in all QOL domains in women
having Stage IV tumors.[18] Moreover, support from family
and health‑care workers (HCWs) reported to have better
QOL outcomes in cancer patients.[19,20]
Many of the recent cancer studies focus on the physical
and psychological adverse effects of chemotherapy
treatment or emphasize on certain specific cancer sites.
However, studies examine the overall QOL components
and its related factors are rare. Thus, this current study
aimed to assess the QOL and its determinants in adult
patients suffering from any type of cancer and undergoing
chemotherapy treatment. The study aimed to answer the
following questions:
1. What is the QOL of adult cancer patients undergoing
chemotherapy treatment?
2. What are the determinants associated with the QOL
of adult cancer patients undergoing chemotherapy
treatment?

Methods
An analytical cross‑sectional study design was used to
answer the research questions.
Participants were recruited using consecutive sampling
strategy from the Oncology Daycare Chemotherapy Unit
of a Tertiary Care Hospital in Karachi, Pakistan. This
chemotherapy bay caters multiple patients daily for the
administration of different chemotherapeutic regimens. The
patients who are admitted belong to different socioeconomic
strata, ethnic background, and education level. Thus, it
provides an opportunity to recruit population with diverse
characteristics. Eligible participants were approached
with the help of patient schedule list and patients’ bedside
nurses taking care of these patients. Researcher recruited
the willing patients after explaining them the research
purpose, procedure, and potential risks and benefits of
the study. Participants were selected on the following
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criteria: (a) patients aged 19 years and older, irrespective
of the site of cancer, (b) patients who had received two
or more cycles of chemotherapy as these patients can
explicitly tell how chemotherapy affect their life in terms of
symptoms, financial burden, societal reaction in relation to
their disease, and many others, and (c) patients who could
speak and understand Urdu or English language. Patients
who were known cases of (a) diabetes, (b) heart disease,
or (c) psychiatric illness, (d) not aware of their diagnosis,
and (e) not willing to participate were excluded from the
research study.
Among 200 cancer patients approached, only 150 patients
were agreed to participate in the study. All the agreed
individuals completed the study questionnaire. All recruited
individuals were provided a written informed consent
before starting the process. The study was approved by
the Institutional Ethical Review Board of the Aga Khan
University, Karachi, Pakistan.
A self‑developed questionnaire was used to collect data
regarding the sociodemographic and clinical characteristics
of the study participants. This questionnaire was based on
the information extracted from the existing literature. It
has five main components inquiring personal and financial
information, chemotherapy treatment and its related side
effects, support system and level of socialization during
treatment. This questionnaire was applied through the
interview.
The tool Functional Assessment of Cancer
Therapy‑General was used to measure the QOL of the
study participants. This tool was developed by a group,
the Functional Assessment of Chronic Illness Therapy
(FACIT) measurement system to measure the QOL of
all types of cancer patients. It consists of 27 questions
measured on a 5‑point Likert scale (0 = not at all, 1 = a
little bit, 2 = somewhat, 3 = quite a bit, 4 = very much).
The tool comprises four common QOL domains: physical,
social/family, emotional, and functional well‑being. The
higher the score, the better the QOL. The original tool
is in English and its translation is also available in Urdu
language. Permission was obtained from the administration
of the FACIT system to use the tool.
The content validity index for the tool was 0.84 for
both relevance and clarity. The value of the reliability
coefficient (Cronbach’s alpha) for the total scale was found
to be 0.88, and for the subscales, it was ranged from 0.86
to 0.70, respectively.
For the purpose of data analysis, statistical package
for social sciences (SPSS) version 19 was used. Mean and
standard deviation (SD) were calculated for normally
distributed continuous variables. For categorical variables,
frequencies and proportions were reported. Multiple
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linear regression analysis was done to identify the factors
associated with QOL of adult cancer patients undergoing
chemotherapy treatment.

Results
Demographic and disease‑related characteristics
Overall, 150 adult cancer patients participated in this
study. Sixty‑six percent of the participants were females.
The mean age of the study participants was 48.23 years. In
relation with the occupational status, 74.0% of the study
participants were unemployed, and more than half of the
participants (76.0%) had a single earning member in their
families. Majority (60.7%) of the study participants or
families belonged to lower middle‑income group [Table 1].
28.7% were breast cancer patients, followed by 19.3% with
ovarian tumors; whereas, the remaining participants were
Table 1: Demographic profile of the adult cancer patients
Characteristics

n=150 (%)

Gender
Male

51 (34.0)

Female

99 (66.0)

Age (years)
19-35

30 (20.0)

36-50

52 (34.7)

51-65

56 (37.3)

>65

12 (8.0)

Marital status
Married

124 (82.7)

Unmarried

24 (16.0)

Separated/divorced/widowed

2 (1.3)

Educational status
Below primary

10 (6.7)

Primary

11 (7.3)

Matric

18 (12.0)

Intermediate

30 (30.0)

Graduation and above

81 (54.0)

Occupational status
Employed

39 (26.0)

Unemployed

111 (74.0)

Earning members
1

114 (76.0)

2

28 (18.7)

>2

7 (4.70)

Monthly income
>20,000

11 (7.3)

21,000-50,000

91 (60.7)

51,000-100,000

41 (27.3)

>100,000

6 (4.0)

Financing of chemotherapy cost
Self-financed

124 (82.7)

Sponsored

19 (12.7)

Donors

7 (4.7)

Values are n (%)
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diagnosed with other cancer sites. Study participants were
receiving palliative (42.0%), adjuvant (31.3%), and (26.7%)
neo‑adjuvant chemotherapy treatment. With regard to
side effects, most of the patients (42.0%) experienced
chemotherapy‑related symptoms, approximately for one
week; however, for the management of these side effects, a
few were hospitalized. Majority (89.0%) of the participants
responded that they had received chemotherapy‑related
education before the initiation of the treatment [Table 2].

Table 2: Clinical characteristics and therapeutics of adult
cancer patient
Characteristics

n=150 (%)

Cancer type
Breast

43 (28.7)

Ovarian

29 (19.3)

Colon/rectum

23 (15.3)

Head and neck

6 (4.0)

Others

49 (32.7)

Disease stage

Quality of life and chemotherapy treatment

I

1 (0.7)

The overall QOL mean score was 57.37, with an
SD of +13.11. With respect to individual domains, the
participants scored best in social/family well‑being with
a mean of 22.33 (SD +3.42) whereas individuals had
lower scores on emotional and physical well‑being, that is,
10.32 (SD +4.95) and 10.41 (SD +5.32), respectively. The
last domain, i.e., functional well‑being, presented a mean
of 14.31 (SD +4.22) [Table 3].

II

17 (11.3)

III

63 (42.0)

IV

64 (42.7)

Type of chemotherapy

Discussion
Our study estimated an average mean score of QOL
as 57.37 depicts poor QOL among adult cancer patients
undergoing chemotherapy treatment. Compared with the
other study conducted on gynecological cancer patients
which reported a score of 62.1, this was considered as
low QOL among patients undergoing chemotherapy
treatment.[44]
Within all the constructs, emotional well‑being appeared
to be the most affected in our study participants, with

40 (26.7)

Adjuvant

47 (31.3)

Palliative

63 (42.0)

Number of chemotherapy sessions received

Determinants of quality of life
The statistical significance of the predictors with mean
QOL was checked out through multiple linear regression
analysis. The final model indicates that 34.1% of the
variability in the mean QOL is explained by female gender
(β = −1.51, P = 0.012), unemployment (β = −1.34, P = 0.032),
parents as caretaker of the patients (β = −1.62, P = 0.03),
and post‑chemotherapy side effects more than a week
(β = −1.186, P = 0.04), which were the factors that resulted
in poor QOL of cancer patients. Moreover, patients who
were avoiding socialization (β = −2.25, P .20.001) due to
the stigma and discriminatory attitude by family/relative
(β = −8.53, P .50.001) also reported a decline in their
QOL, whereas no hospitalization due to the chemotherapy
side effects (β =1.43, P = 0.01) and no other significant
changes in the life during the treatment phase (β =1.56,
P = 0.01) were the determinants contributed to better
QOL [Table 4]. With respect to the Pakistani culture, the
determinants which mainly affect these patients’ QOL were
being a female cancer patient, side effects of chemotherapy
medicines, and reluctant to socialize due to stigmatization.

Neo-adjuvant

2-5

84 (56.0)

6-10

45 (30.0)

11-15

17 (11.3)

>15

4 (2.70)

Duration of postchemotherapy side effects
2-3 days

47 (31.3)

1 week

63 (42.0)

>1 week

40 (26.7)

Hospitalization
Yes

34 (22.7)

No

116 (77.3)

Information received
Yes

134 (89.3)

No

16 (10.7)

Values are n (%)

Table 3: Quality of life scores in all four domains of the
functional assessment of cancer therapy‑general tool
Domains

n

Minimum

Maximum

Mean

SD

Physical well-being

150

2

24

10.41

5.321

Social/family well-being

150

11

27

22.33

3.422

Emotional well-being

150

2

23

10.32

4.954

Functional well-being

150

5

25

14.31

4.227

Overall QOL

150

29

92

57.37

13.11

P=0.05 is significant, QOL: Quality of life, SD: Standard deviation

a score of 10.32. Consistent with the study carried out
among Turkish cancer patients, a lower score of 9.07 was
identified.[21] Similarly, a study carried out among breast
cancer patients in Brazil also reported emotional well‑being
as the most negatively affected dimension of QOL.[45]
The findings of this study showed that poor physical
health is associated with lower QOL. Lack of energy
(that is fatigue) and nausea/vomiting were the most
common side effects reported by the study participants.
Concurrent with the previous studies, chemotherapy was
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Table 4: Multivariable analysis of determinants associated with
quality of life
Characteristics

β (SE [β])

95% CI

P

Female

−1.51 (0.594) −2.69-−0.34

0.012

Unemployed

−1.34 (0.619) −2.56-−0.11

0.032

Chemotherapy side effects (>1 week) −1.186 (0.589) −2.3-−0.020

0.046

No hospitalization

0.010

Parents (as caretaker)
No significant change

1.435 (0.548)

0.340-2.52

−1.620 (0.742) −3.08-−0.15
1.56 (0.619)

0.342-2.79

0.031
0.013

No socialization

−2.256 (0.523) −3.29-−1.22 <0.001

Discrimination by family/relatives

−8.535 (1.984) −12.45-4.61

0.000

FACT‑G: Functional assessment of cancer therapy‑general, QOL: Quality of life,
CI: Confidence interval, SE: Standard error

highly associated with severe fatigue and nausea among
cancer patients which affected their ability for self and
family care.[11,22]
Similar to the existing literature, the current study also
showed that the female gender was significantly associated
with the poor QOL. Generally, females are identified
with efficiency in household work and childbearing and
rearing. Women adapt these behaviors happily as a cultural
norm. Moreover, this perception is a bigger reality for the
traditional Pakistani society. Disturbance in these practices,
due to the disease and its treatment, will greatly influence
their QOL.[23,24]
It is well‑recognized that patients who experienced
economic hardships are at the higher risk for developing
distress. Our study has found a negative significant
association between the financial status and QOL.
These results are consistent with some of the previous
investigations.[25‑28] This finding is not surprising because
chemotherapy is a prolonged and expensive treatment
which creates financial burden among the cancer patients.
In the developing country like Pakistan, this is even worse
as majority of the population belonged to lower‑middle
class families and had one earning member who solely
responsible for all family expenditure.
This situation poses an additional financial burden, along
with the usual household expenses, on cancer patients and
their families.
Although it is apparent that cancer itself affects the
physical functioning of a person, with the effects of
chemotherapy treatment, it becomes worse. This study
revealed that longer duration of post chemotherapy side
effects (more than a week) impacts negatively on the
QOL; these findings were also in line with the existing
literature.[29‑32] Several other researches indicate frequent
hospitalization due to chemotherapy adverse effects.[33‑35]
On the contrary, in the current study, although a majority
of the study participants faced severe side effects for a week
or more, a few hospitalizations were reported by them. The
low number of hospitalization in the present study could be
144

explained by the findings that the majority of the patients
were educated by the HCWs about the management of
chemotherapy side effects, before starting the actual therapy.
This received knowledge may have facilitated them in
handling their side effects effectively at home.
Participants who experienced any significant change
(i.e., loss of a loved one), along with the disease, showed
poor QOL. Any major life event with the course of
treatment could enhance stress and negative thinking in
cancer patients. This, ultimately, affects patients, both
physically and emotionally, which further worsens their
well‑being. Another finding of our study was that a majority
of patients were avoiding socialization which adversely
affects their QOL, which is also substantiating by other
studies.[36‑39] The findings also indicated that most of the
patients avoided going out because of alopecia. Patients
avoid socialization as they do not appreciate the starring
and sympathizing looks of strangers.[13]
Parents are among the caretakers who are extremely vital
in obtaining favorable results of the patients’ treatment.
However, in this study, it was seen that those patients who
were taken care by their parents exhibited a poor QOL. One
of the probable explanations for this could be that the cancer
patients considered themselves as a burden for their families,
which subsequently affected their QOL.[40] In the Pakistani
culture, parents have a unique status and they are treated
with great respect. In addition, adult children are supposed
to look after their parents’ needs and finances in their older
ages.[41] However, when a son or daughter is diagnosed
with cancer, the responsibilities shift toward the parents,
which become an additional source of burden during their
older age.[36] The sense of self‑guilt and nonfulfillment of
responsibilities toward their parents may create frustration
in cancer patients and affecting their emotional well‑being.
Religion has a special place in an individual’s life. The
study findings showed that a majority of the patients found
religious help as their priority coping mechanism, which
is consistent with the findings of a previous study done
in Pakistan.[7] The regular recitation of prayers and other
rituals helps in coping with an illness and is considered as
a hope for the future; hence, they develop a positive effect
on QOL in cancer patients.[42‑43]
In Pakistan, very limited studies were conducted to
address the QOL concerns of adult cancer patients;
therefore, the findings of this study will potentially facilitate
health policymakers and researchers for planning further
investigations and patients care plans.

Limitations
The current study has certain limitations which need to
be considered. Patients were recruited from single private
health‑care setting, therefore; the findings of the study
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have limited generalizability and are applicable only to
the similar settings. In our study, the ratio of female to
male participants was greater which may have affected the
findings of this study. Keeping in mind the time limitation
for this project, only a quantitative design was employed
in this study. However, a mixed method approach could
have given a better understanding of the concept of QOL
in cancer patients receiving chemotherapy.

Conclusion and Recommendation
The findings of the current study indicate poor QOL
among adult cancer patients undergoing chemotherapy
treatment in Karachi. Moreover, the study results identify
emotional and physical wellbeing as severely affected
domains of QOL. Gender, occupational status, post
chemotherapy side effects, lack of socialization, and
discrimination, and a few other factors were the significant
determinants of QOL. It is vital to initiate certain
strategies for cancer patients to alleviate their physical and
psychological sufferings and subsequently improving QOL.
This study recommends the following:
1. Strategies such as cancer support groups and
psychological screening in the regular assessments can
potentially help lessen emotional distress in cancer
patients undergoing chemotherapy
2. Educate patients and their families regarding the
management of chemotherapy treatment, this minimizes
frequent hospitalizations and helps in obtaining better
patients health outcomes
3. Public awareness campaigns about the disease and
its effects need to be organized, which may help in
eliminating the stigma and misconceptions regarding
cancer and its treatment
4. A multidisciplinary team needs to be on board to resolve
cancer patients’ issues without any wastage of time.
Cancer is a major public health concern which not
only affects patients’ physical health but also influences
their overall QOL. Considering the severity of this
disease and its effects, it is necessary to identify factors
associated with the betterment or deteriorating the
patient’s QOL. Our study found few of those factors
which potentially help in making patients care plans and
further initiate certain strategies which will contribute
toward better QOL outcomes. Moreover, further studies
were recommended to identify determinants that have
not been investigated in the current study. Longitudinal
studies are required to establish causal relationship
between the variables.
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